Navigation Links
Lack of Medicare Part D Coverage for All Medically Necessary Prescriptions Endangers Older Americans and Those with Chronic Diseases and Disabilities

Coalition of Patient and Consumer Groups calls for Legislative Action to

Ensure Access to 'Off-Label' Drug Treatments

WASHINGTON, Nov. 20 /PRNewswire-USNewswire/ -- Twenty-six patient, family caregiver and health professional organizations are calling upon Congress to pass legislation to require Medicare prescription drug plans to provide access to all medically accepted uses for the drugs they cover.

Medicare regulations exclude Part D coverage of a medication if it is prescribed for a use that is not on the Food and Drug Administration (FDA) label or supported by a citation in one of three specific medical compendia. In a sign-on letter to the Senate, the organizations wrote that the "exclusive reliance on FDA indications and a limited number of compendia prevents access to medically necessary, life-sustaining prescriptions."

Over 20 percent of the 500 most commonly prescribed drugs are used for off-label treatments. According to the letter, "People with cancer, HIV/AIDS, lupus, multiple sclerosis, debilitating pain, and mental health conditions, and other rare and serious conditions are routinely prescribed drugs off-label to manage disease symptoms and progression." The letter is available at

"We know of a number of people who have been hospitalized or been required to take other more expensive treatments because they did not have access to their prescribed medicines," said Andrew Sperling, Director of Legislative Advocacy, National Alliance on Mental Illness.

For specific cases and more information, see the Medicare Rights Center's report, "Off-Base: The Exclusion of Off-Label Prescriptions from Medicare Part D Coverage," available at

Medicare's Part D regulations on off-label use are inconsistent with the more expansive Part B regulations, which allow for consideration of evidence of effectiveness in peer-reviewed literature in addition to the FDA label and the compendia. Part B's prescription drug coverage includes certain injectable cancer drugs and immunosuppressive drugs.

"As HIV clinicians, we are asking for the ability to present published data during the exceptions process that would demonstrate compelling evidence that an individual patient would benefit from treatments that cannot be covered by Medicare Part D programs under the current rules," said Bruce Williams, MD, MPH, a member of the HIV Medicine Association. "Often the debilitating effects of HIV or its treatments are best treated with medications that may not have been approved specifically for people with HIV/AIDS or for a specific condition, despite strong evidentiary support for the use in the medical literature."

The sign-on letter specifically urges Congress to amend the Medicare statutes to make Part D coverage of off-label uses consistent with Part B, allowing for consideration of peer-reviewed literature in determining coverage.

Medical Access for Patients Rx (MAPRx), a coalition of patient, family caregiver and health professional organizations, is working with other allied groups to build support for a Congressional action on this issue.

MAPRx is a coalition of patient, family caregiver and health professional organizations committed to safeguarding the well-being of patients with chronic diseases and disabilities under Medicare Prescription Drug Coverage. MAPRx member organizations collaborate with national and state policymakers to ensure that beneficiaries have the access to the medication therapies they need and deserve.

Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Local Medicare Contractors Expand Hypertension Coverage for CardioDynamics BioZ(R) ICG Technology
2. Medicare Contractor Establishes Reimbursement Coding Guidance for Monograms Trofile Assay
3. Oncologists Call For Medicare to Reconsider Anemia Drug Restrictions
4. Mayo Clinic Study Finds FDA Warning Against Anti-Nausea Drug Droperidol Unnecessary
5. CEL-SCI Corporation Releases Letter to Shareholders
6. Aspirin Named 8th World Wonder by Majority of Americans
7. Actress and Mother Jennifer Garner Joins American Lung Association to Encourage Americans to Get an Influenza Vaccination
8. Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
9. UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
10. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
11. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
Post Your Comments:
(Date:11/25/2015)... 2015 Kitov Pharma ceuticals ... a biopharmaceutical company focused on the development of therapeutic ... today announced the closing of its previously announced underwritten ... ), each representing 20 ordinary shares of the Company, ... ADSs and warrants were issued in a fixed combination ...
(Date:11/25/2015)... -- Allergan plc (NYSE: AGN ) today announced that ... York State Attorney General,s Office to end the ... statutes with the Attorney General over the decision of Forest ... selling the now generic version of memantine immediate release tablets.  ... released its counterclaims against New York , ...
(Date:11/25/2015)... -- Trovagene, Inc. (NASDAQ: TROV ), a developer of ... Antonius Schuh, Ph.D., is scheduled to present a corporate ... Healthcare Conference. th Annual Piper Jaffray ... New York on Tuesday, December ... be available for one-on-one meetings during the conference. The ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... 25, 2015 , ... The McHenry County law firm of Botto Gilbert ... Attorneys Francisco J. Botto and Alex C. Wimmer. Attorneys Botto and Wimmer represented the ... App (2d) 130884WC. , According to court documents, Adcock testified that on May 10, ...
(Date:11/25/2015)... ... November 25, 2015 , ... On November 23rd 2015 Cozy ... personal heating products business. Cozy Products explains what this means for business moving ... well with the Cozy Products business model: to sell personal heaters that reduce energy ...
(Date:11/25/2015)... ... November 25, 2015 , ... Smiles by Stevens is ... and moderate facial wrinkling. While many patients are aware of the benefits of Botox® ... Botox® delivers to those suffering with discomfort, soreness, and pain as a result of ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... a double board certified facial plastic surgeon specializing in both surgical and non-surgical ... of The Skin Spa at Hobgood Facial Plastic Surgery. , Highly trained ...
(Date:11/25/2015)... ... 2015 , ... Beddit® has launched a new Android app for ... features a more intuitive SleepScore™ that rates sleep quality on a 100-point scale and ... created by a proprietary algorithm. Beddit analyzes the data to provide an easy to ...
Breaking Medicine News(10 mins):